Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-01

Clinical Trial Update: Amantadine for Neuroenhancement in Acute Patients Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on amantadine for neuroenhancement in patients with disorder of consciousness; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Disorder of Consciousness | Phase 2 | Status: UNKNOWN